SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001829126-24-002251
Filing Date
2024-04-05
Accepted
2024-04-05 16:34:04
Documents
1
Group Members
SEOW GIM SHEN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A titanpharma_sc13da1.htm SC 13D/A 80533
  Complete submission text file 0001829126-24-002251.txt   82199
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46083 | Film No.: 24826992
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address NO. 4, FRANKY BUILDING PROVIDENCE INDUSTRIAL ESTATE MAHE T2 00000
Business Address NO. 4, FRANKY BUILDING PROVIDENCE INDUSTRIAL ESTATE MAHE T2 00000 6012 484 4444
Sire Group Ltd. (Filed by) CIK: 0001995392 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY
Type: SC 13D/A